Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production.

[1]  Motowo Nakajima,et al.  Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  A. Arlt,et al.  Autocrine Production of Interleukin 1β Confers Constitutive Nuclear Factor κB Activity and Chemoresistance in Pancreatic Carcinoma Cell Lines , 2002 .

[3]  I. Fidler,et al.  Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma. , 2001, International journal of oncology.

[4]  T. Gress,et al.  TGF‐β–induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase‐2 and the urokinase plasminogen activator system , 2001, International journal of cancer.

[5]  V. Dessirier,et al.  Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. , 2001, Carcinogenesis.

[6]  M. Tatsuta,et al.  Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. , 2001, Cancer research.

[7]  K. Matsumoto,et al.  NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells , 2001, British Journal of Cancer.

[8]  K. Matsumoto,et al.  HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. , 2000, Cancer research.

[9]  M. Monden,et al.  Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase–polymerase chain reaction assay , 2000, Cancer.

[10]  Christopher Haslett,et al.  Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo , 1999, Nature Medicine.

[11]  Kunio Matsumoto,et al.  Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor , 1998, Oncogene.

[12]  S. Nakano,et al.  Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans. , 1998, Cancer letters.

[13]  Toshikazu Nakamura,et al.  HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor , 1997, FEBS letters.

[14]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor. , 1997, Biochimica et biophysica acta.

[15]  B. le Bail,et al.  Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: Evidence for a role of hepatocyte growth factor , 1997, Hepatology.

[16]  K. Matsumoto,et al.  Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. , 1997, Cancer research.

[17]  Y. Doki,et al.  Primary Human Fibroblasts Induce Diverse Tumor Invasiveness: Involvement of HGF as an Important Paracrine Factor , 1996, Japanese journal of cancer research : Gann.

[18]  Toshikazu Nakamura,et al.  Acquisition of Invasive Phenotype in Gallbladder Cancer Cells via Mutual Interaction of Stromal Fibroblasts and Cancer Cells as Mediated by Hepatocyte Growth Factor , 1996, Japanese journal of cancer research : Gann.

[19]  T. Nakamura,et al.  Differential tubulogenic and branching morphogenetic activities of growth factors: implications for epithelial tissue development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Poulsom,et al.  Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. , 1995, Cancer research.

[21]  L. Orci,et al.  Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. , 1995, Journal of cell science.

[22]  A. Joseph,et al.  Regulation of scatter factor production via a soluble inducing factor , 1994, The Journal of cell biology.

[23]  T. Nakamura,et al.  Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors. , 1993, Cancer research.

[24]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[25]  H. Kern,et al.  Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico‐histopathological correlation in a series of 75 cases , 1985, Histopathology.

[26]  S. Nakano,et al.  Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells , 2004, Clinical & Experimental Metastasis.

[27]  K. Miyazawa,et al.  Tyrosine Phosphorylation of β-Catenin and Plakoglobin Enhanced by Hepatocyte Growth Factor and Epidermal Growth Factor in Human Carcinoma Cells , 1994 .

[28]  T. Hsu,et al.  Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.